The authors highlighted that the expression of three DEG genes (caspase 4 (CASP4), caspase 1 (CASP1), and phospholipase A2 group IVA (PLA2G4A)) were upregulated in SCOS patients. The gene discussed is CASP1; the disease is small cell osteogenic sarcoma.